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ABSTRACT
Capsid-displayed adenoviral peptide libraries have
been a significant, yet unfeasible goal in biotechnol-
ogy. Three barriers have made this difficult: the
large size of the viral genome, the low efficiency of
converting plasmid-based genomes into packaged
adenovirus and the fact that library amplification is
hampered by the ability of two (or more) virus to
co-infect one cell. Here, we present a novel vector
system, pFex, which is capable of overcoming all
three barriers. With pFex, modified fiber genes are
recombined into the natural genetic locus of ade-
novirus through unidirectional Cre–lox recombina-
tion. Modified-fiber genes can be directly shuttled
into replicating viral genomes in mammalian cells.
The ‘acceptor’ vector does not contain the fiber
gene, and therefore does not propagate until it
has received a ‘donor’ fiber gene. Therefore, this
methodology overcomes the low efficiency of
transfecting large viral genomes and bypasses the
need for transition to functional virus. Thus, with a
fiber-shuttle library, one can generate and evaluate
large numbers of fiber-modified adenovirus simul-
taneously. Finally, successful fiber genes can be
rescued from virus and recombined back into
shuttle plasmids, avoiding the need to propagate
mixed viral pools. For proof of principal, we use this
new system to screen a capsid-displayed peptide
library for retargeted viral infection.
INTRODUCTION
The translation of adenoviral vectors as therapeutic agents
has been hampered, in part, by broad viral tropism
and diminished expression of the Coxsackie and
adenoviral receptor (CAR) in many cancers. To overcome
these limitations, genetic strategies have been developed
to detarget the virus away from natural infection
pathways and to retarget viral infection to alternative
receptors through modiﬁcations to capsid genes.
Unfortunately, the large viral genome and complex
major late gene organization have made capsid
gene alterations challenging. Moreover, capsid gene
alterations can often interfere with protein structure,
viral packaging and infection. Thus, with current technol-
ogy, adenoviral retargeting by genetic alterations can be
a risky endeavor.
Nevertheless, there are several examples where adeno-
viral tropism has been successfully directed to refractory
cells and tissues through capsid-displayed peptides and
proteins on viral ﬁber (1), penton base (2), hexon (3) and
protein IX (4). Of these methodologies, ﬁber-displayed
peptides have been the most successful and most widely
applied (5). Moreover, it was recently discovered that the
ﬁber protein was responsible for non-CAR mediated liver
infection and sequestration through interactions with
certain blood factors (6). The mutation of ﬁber regions
that interact with these blood factors signiﬁcantly reduces
both liver clearance and immune-induced hepatic toxicity.
Therefore, alterations to the ﬁber gene alone can result
in novel cell targeting, improved in vivo biodistribution
and reduced toxicity. In addition, the ﬁber gene region
provides a new site for incorporating transgenes, where, if
desired, gene expression can be temporally restricted to
viral replication through linkage to major late transcrip-
tional unit (MLTU) expression (7–10). Thus, the ﬁber
gene region has been a major focus of the next generation
of adenoviral vectors.
Here, we present a new vector system for generating
ﬁber-modiﬁed adenoviruses. The system is robust, allow-
ing one to shuttle modiﬁed ﬁber genes into adenoviral
plasmids in Escherichia coli or into replicating adenovirus
genomes in mammalian cells. The eﬃciency and sensitivity
are such that ﬁber-gene libraries can be generated and
screened.
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Cells and culture
The 293 cells (Quantum Biotech), FBJ cells and 293cre57
cells were maintained in Dulbecco’s MEM (DMEM) with
10% FBS. The 911–S11 cells were maintained in DMEM
with 5% FBS and 200mg/ml G418. The 911–S11 cells
express a previously characterized membrane-bound anti-
ﬁber single chain antibody as a pseudo-receptor (11). The
DPL-37 cells were maintained in DMEM with 10% FBS
and 10mMMgCl2. The PC-3 cells were obtained from
ATCC (Manassas, VA, USA) and maintained in RPMI
medium supplemented with 10% FBS. PC3-CAR was
provided by Dr Hsieh (12). All medias were supplemented
with Ciproﬂoxacin Hydrochloride 5mg/ml (US Biological,
Swampscott, MA, USA) and Gentamicin 50mg/ml
(Quality Biological Inc., Gaithersburg, MD, USA). All
cells were maintained at 378C in an atmosphere containing
5% CO2.
Generationof plasmid vectors
The pFex plasmid was assembled through several steps.
First, ‘distal to ﬁber AgeI’ was created by PCR ampliﬁca-
tion and cloning with primers AdE-Dist 50 and AdE-Dist
30 (Supplementary Table S2) into pCR-2.1 to produce the
vector ‘Step 1 pFex’. Second, ‘proximal to ﬁber’ was
created by PCR ampliﬁcation with primers loxmve1 and
loxmve2 and subcloning into ‘Step 1 pFex’ using the SpeI
and AgeI. The resulting vector is ‘Step 2 pFex’. The SacB
gene was isolated from pAJ200 using the BglII and PvuI
restriction sites. Next, the two half mutant lox sites, lox
m2/66 and lox 71, were added by ligation with self
annealed linkers 50 lox m2/66 and 30 lox m2/66, and 50 lox
71 and 30 lox 71, respectively. The resulting ﬂoxed SacB
gene was then subcloned into Step 2 pFex to create ‘Step 3
pFex’. Finally, the modiﬁed segment was subcloned into
pAdEasy-1 with SpeI and PacI, replacing the pre-existing
region. The ﬁnal vector construct is called pFEX and was
veriﬁed by sequencing using primers pFEXfor01-11 and
pFEXrev01-11 (Supplementary Table S2).
Fiber shuttle vectors were also constructed in a stepwise
manner. The pBK-CMV-ﬁber (a generous gift from Drew
Pardoll and Sara Pai, Johns Hopkins) contained three
mutations, A32665T, A32667C (which created a unique
BspEI site in the ﬁber-HI loop) and A32651G (N541S
ablative mutation). Adenovirus containing the ﬁber
N541S mutation are unable to infect or propagate
[Figure 3, far left column 0:1 (WT:N541S) produces no
viral bursts or plaques]. The pBK-CMV-ﬁber was digested
with the SpeI and XhoI and the linkers S-lox m2/71-X5
and S-lox m2/71-X3 (Supplementary Table S3) were
self-annealed and ligated into the vector creating ‘Step 1
ﬁber Shuttle Lox m2/71’. The linkers N-Lox 66-A-5 and
N-Lox 66-A-3 were then subcloned into this vector by
Acc65I and NotI, making ‘RP-Fib1’. The tripartite leader
(TPL) splice acceptor site was subcloned downstream of
the lox m2/71 site with linkers splce1 and splce 2 creating
RP-Fib1R1. For CAR-ablated vectors, pBK-CMV-
TAYT-ﬁber (Ad5 nucleotides 32506–32518, amino
acids T489AYT492) was subcloned into shuttle through
XhoI/NotI, creating ‘RP-Fib2’. The TPL splice acceptor
was cloned as above creating ‘RP-Fib2R1’. Finally,
plasmids RP-FBR1 and RP-FBR2 were generated by
reverting the A32651G (N541S) mutation to wild-type
with primers 5FBR-537REP and 3FBR-537REP and
BglII and BspEI subcloning. To generate Ampicillin
resistant versions, the ﬂoxed cassettes were subcloned
into Puc19 through KpnI and SpeI, creating RPuc-Fib1,
RPuc-Fib2, RPuc-Fib1R1, RPuc-Fib2R1, RPuc-FBr1
and RPuc-FBR2. RPuc-RGD4C-2 was created in two
steps. First, annealed primers 5N-Dir and 3N-Dir were
subcloned into the HI-loop BspeI site. Linkers 50RGD and
30RGD were then annealed and subcloned into the vector.
RPuc-WTFib and RP-WTFib, were generated with
primers WTFibFix-1 and WTFibFix-2 and subcloning
through NcoI and NotI. RPuc-Rescue was generated by
PCR ampliﬁcation of SacB with primers Not-SacB
(AATTGCGGCCGCCACTATTATTTAGTGAAATGA
GATATTA) and Xho-SacB (ATCTCGAGAGAAGT
GATGCACTTTGATATCGACCCAAG) and subse-
quent cloning into RPuc-FBR1, replacing ﬁber with SacB.
All ﬁber shuttle vectors were sequenced with primers
M13 forward, M13 Reverse, ﬁber-S2 and ﬁber-S3.
Generation and evaluation ofadenovirus through
plasmid-based recombination
The pAdTrack was recombined with the pFex plasmid
vector either before or after ﬁber-region recombination in
BJ5183 E. coli either by co-electroporation or by ﬁrst
generating a stable pFex-based BJ5183 coli followed
by electroporation of the AdTrack shuttle vector (13,14).
Recombinant vectors were propagated in DH5a.
For ﬁber-region recombination, 10ng of pFex was
transformed with the 10ng ﬁber shuttle vector into 40ml
of electrocompetent 294cre coli (Gene Bridges GmbH,
Dresden, Germany) in a 0.2cm cuvette at 2.5KV,
200 ohms and 25mFd (BioRad Gene Pulser). Following
electroporation, samples were resuspended in 1.0ml SOC
broth, incubated at 428C for 20min and then shook
vertically (225rpm) at 378C for 1h. Recombinant
plasmids were selected on appropriate antibiotic LB agar
plates containing 5–7% sucrose. Clones were ampliﬁed,
mini-prepped and the resulting plasmid electroporated
into DH5a coli. In some cases, PCR was applied prior to
DH5a transformation to detect the presence of recombi-
nant clones (see ‘Recombination-speciﬁc PCR’ section
subsequently and Figure 2B). Recombinant plasmids were
screened by XhoI restriction mapping and conﬁrmed by
DNA sequencing. Viral plasmid products were linearized
by PacI digestion and transfected into the desired
packaging lines (293 or 911–S11). Viruses were step
ampliﬁed to 5 150mm
2 ﬂasks and then puriﬁed by
commercial adenovirus puriﬁcation kit (Adenopure
TM,
Puresyn, Inc., Malvern, PA, USA). Benzonase was used in
the puriﬁcation process. Resulting virus were titered by
Adeno-X
TM Rapid Titer Kit (BD Biosciences). The
correct splicing pattern upstream of the recombinant
ﬁber gene was conﬁrmed by reverse transcription of total
RNA harvested from infected cells (Trizol, Invitrogen),
followed by PCR ampliﬁcation with primers Fib-RT1
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UCUUCAGACGGUCUUGCG), TOPO-TA cloning
(pCR-21-TOPO, InVitrogen) and sequencing. These
results conﬁrmed natural linkage of the TPL to the ﬁber
coding region.
Recombination-specific PCR
Colony PCR was applied to conﬁrm recombination of
the ﬁber gene into pFex. Primers ﬁber-S2 and pFexrev07
produce a 1.6Kb product that is speciﬁc for ﬁber
containing clones (Figure 2B). Note that the PCR product
size depends on the content of the ﬁber gene cassette. PCR
primers pFexfor08 and pFex rev02 were used for posi-
tive controls. Clones positive by these assays were
then mini-prepped and transformed into the more stable
DH5a coli.
Efficiency of plasmid-based recombination
The 294cre E. coli were electroporated with 50ng of pFex
plasmid and 10-fold molar excess ﬁber shuttle. Cells were
heat shocked for 20min and grown for 2h at 378C,
225r.p.m. Clones were quantiﬁed on LB+50mg/ml Kan
for pFex containing colonies, LB+100mg/ml Amp for
ﬁber shuttle colonies and LB+7% sucrose+50mg/ml
Kan as colonies per milliliter of growth medium.
Generation and evaluation ofadenovirus through
mammalian cell-based recombination
The ﬁber-less pAdTrack-Fex plasmid was pseudotyped
by PacI digestion and transfection into the ﬁber gene
expressing FBJ cell line (a generous gift of Dr David
Johns, Johns Hopkins). Pseudotyped AdTrack-Fex virus
was ampliﬁed, puriﬁed and titered as described earlier.
For ﬁber gene recombination, approximately 10
6 293cre57
cells (15) (a generous gift of Dr Stephen Langer,
University of Colorado) were transfected with 2mgo f
ﬁber shuttle plasmid through magnet-assisted transfection
(MATra-A, IBA, St Louis, MO, USA) in a 6-well plate,
immediately followed by infection with pseudotyped
AdTrack-Fex [multiplicity of infection (MOI=1)]. After
3–5 days of transfection and infection, cells were harvested
by scraping and virus eluted by 3–4 freeze per thaw cycles.
The resulting supernatant was then used to infect 293
or 911–S11 cells.
Evaluation of purified adenoviral particles
The 10
6 plaque forming units (PFU) of each puriﬁed
adenovirus were boiled in Laemmli buﬀer for western blot
analysis. Blots were probed with 4D2 anti-ﬁber antibody
(Abcam, Cambridge, MA, USA), anti-mouse IgG-HRP
(Sigma, St Louis, MO, USA) and developed by ECL-Plus
HRP detection assay (GE Healthcare). For PCR detec-
tion, 10
5 PFU was boiled and DNA subjected to Hexon
(primers Ad5Hexon sense: ATGGCTACCCCTTCGAT
GAT and Ad5Hexon antisense: GATGAACCGCAGC
GTCAAAC; 207bp product) and ﬁber HI-loop [primers
HIFlnk: TTCATTAATGTAGTTGTGGC and knlFIH:
ACCATTACACTAAACGGTAC; 101bp for wild-type
and CAR-ablated (TAYT) vectors and 140bp for
RGD4C vectors] PCR. PCR products were separated on
agarose gel and stained with ethidium bromide.
Serial dilution experiments
RPuc-WTFib was serially diluted from 1:10 to
1:1000000 and mixed into a total of 3mg of Rpuc-
Fib1R1 (N541S). A negative control of N541S alone was
also included. Shuttle dilutions were transfected into
293cre57 cells and immediately infected with pseudotyped
AdTrack-Fex (MOI=1). Five days later, recombinant
virus was harvested and used to infect 293 cells in 100mm
plates (2—5h). Cells were overlayed with noble agar and
viral bursts allowed to form for 3–7 days. Only RPuc-
WTFib recombinant virus form GFP-positive viral bursts
(as in Figure 3, box arrow). Some pFex or N541S virus are
infectious by complementation; however, these virus fail
to spread and only appear to occupy a single cell
(Figure 3, small arrows). The number of viral bursts was
counted for each dilution to determine the sensitivity of
detecting a single working ﬁber shuttle plasmid in the
background of extensive mutant ﬁber shuttles.
Tropism studies
Four separate tropism studies were performed. First,
5 10
5 PC-3 and PC3-CAR cells were infected with
AdTrack-WTFib, AdTrack-FBR2 or AdTrack-RGD4C-
FBR2at MOIs of 100 for 2h in 6-well dishes. Infected
cells were visualized 48—72h post-infection by ﬂuorescent
and light microscopy. Collected images were overlayed to
demonstrate number of cells infected and non-infected.
In a second study, clones from the library selection, and
CAR-ablated and wild-type controls were used to infect
293 cells (24h after plating) with an MOI of 0.1. Ten ﬁelds
of GFP-positive infected cells were counted 24h after
infection and results plotted as percent infected cells
relative to wild-type ﬁber control. Finally, experiments
investigating CAR-independent infection were performed
in 96-well plate format. For anti-CAR siRNA experi-
ments, 1 10
4 293 cells were plated and transfected
with 5 nM of siRNA [Hs_CXADR_10 HP siRNA,
Hs_CXADR_11 HP siRNA, All-Stars negative control
siRNA or untransfected using HiPerfect Transfection
Reagent (Qiagen, Valencia, CA, USA)]. Cells were
infected with adenovirus (MOI=1 and 10) for 2h as
triplicate samples, 72h after transfection. For CAR
overexpression experiments, 1 10
4 PC-3 or PC3-CAR
cells were plated in 96-well plates. Cells were infected the
next day with each adenovirus (MOI=10 and 100) for 2h
in triplicate samples. For both studies, infection was
quantiﬁed at 24—48h post-infection by ﬂuorescent
microscopy (6 , equal exposure rates and processing)
and ﬂuorescent intensity (FLUOROstar Optima BMG
ﬂuorometer). Statistical signiﬁcance was determined by
Student’s t-test.
Adenoviral peptide library
Primers for the random hexapeptide library, Bsp-Lib and
Rnd-ext (BSP-Lib: TGGAGTTGTGTCTCCGGANNN
NNNNNNNNNNNNNNNTCCGGATTCCTGTGTAC
CGCT; Rnd-ext: 5AGCGGTACACAGGAATCCGGA)
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Biotinylated primers Lib001 (Biotin-AGCGGTACACA-
GGAATCC) and Lib002 (Biotin-TGGAGTTGTGTCT
CCGGA) were then used for PCR ampliﬁcation, and the
resulting product was digested with BspEI. Flanking
digestion products and uncut product were removed
with streptavidin magnetic beads (New England
Biolabs). The resulting library fragment was subcloned
into RPuc-FBR2. Ligation conditions were optimized and
large-scale electroporation to DH5a was used to generate
 16000 clones of the RPuc-FBR2-6X library. To generate
library virus, 10
6 293cre57 cells were transfected with 3mg
of RPuc-FBR2-6X and infected with pseudotyped
pAdTrack-Fex (MOI=1). Five days later, cells and
media were harvested, freeze-thawed and lysate was used
to infect 293 cells on 100mm plates. Infections were
overlayed with agar and viral infection visualized by
ﬂuorescent microscopy. Both positive (RPuc-WTFib) and
negative (N541S) shuttles were included for reference.
Viral bursts were counted 48h after infection and plaques
isolated at later time points in 293 cells. Aliquots of viral
lysate were treated with proteinase K, boiled and used to
PCR amplify the ﬂoxed ﬁber region (FF01: TGTTC
CTGTCCATCCGCACCCACTATCTTCATGTTG and
FF02: AGGACTGTGTACTCTGTGTGTTGGGAGG
GAGGTGGCA). The resulting PCR product was recom-
bined with RPuc-Rescue in 294cre E. coli as described in
the ‘Plasmid-based recombination’ section. Selected ﬁber
clones were conﬁrmed by restriction mapping and
sequencing.
RESULTS
Design ofthe vector system
We have generated a novel vector system for modifying
the ﬁber gene region of the widely applied Adenovirus
vector, pAdEasy-1 (13). The vector system, outlined in
Figure 1, applies an ‘acceptor’ vector, pFex, and ﬁber
‘donor’ vectors, RP-FBR or RPuc-FBR (depending on
required antibiotic). The pFex acceptor vector is a
modiﬁed version of AdEasy-1, where the ﬁber gene and
upstream TPL splice-acceptor-site (Ad5 nucleotides
31023–32768) have been replaced with the Bacillus subtilis
(SacB) gene. SacB imparts negative selectivity to bacteria
grown in 5% sucrose and thus oﬀers a means to negatively
select against non-recombined acceptor vectors (16).
Correspondingly, the donor vectors contain the modiﬁed
ﬁber gene, TPL splice acceptor site and regions for
additional transgene incorporation. Both donor and
Figure 1. Methods for site speciﬁcally transferring modiﬁed ﬁber gene cassettes into adenoviral plasmid vectors or replicating viral genomes in
mammalian cells through unidirectional Cre–lox-mediated recombination. (A) The large viral plasmid vector pFex has two regions for accepting
transgene cassettes, the Amp-resistant-E1-region cassette and the SacB-ﬁber-region cassette. The ﬁber-region-cassette can be recombined before
(bottom) or after E1-region-cassette recombination (top). E1 cassettes are recombined through homologous recombination of adenovirus left-hand
and right-hand homology regions in RecA positive BJ5183 coli. Recombinant plasmids are selected according to the newly acquired resistance
cassette. On the other hand, ﬁber cassettes are recombined through half-mutant lox site (see legend: Green, wild-type half site; Red, mutant half site;
Black and Gray represent non-compatible spacers) recombination in Cre recombinase expressing coli. Non-compatible spacers (gray center versus
black center) prevent intragenic recombination. The resulting recombinant plasmids are selected by growth on sucrose containing plates. Following
recombination, the donor plasmid product contains fully mutant lox sites (red circles), where the resulting recombinant vector contains fully wild-
type lox sites (green circles); therefore, preventing any further recombination between the shuttles and viral vectors. The ﬁnal resulting vectors are
linearized and transfected into mammalian packaging cells to create viral particles (B) Fiber gene cassettes can be directly shuttled into adenoviral
genomes in mammalian cells. E1-cassette-containing pFex vectors, such as AdTrack-pFex, can be pseudotyped (packaged in cells that express wild-
type ﬁber) and used to infect packaging cell lines that express Cre recombinase. Transfection of infected cells with a ﬁber-gene shuttle results in site
speciﬁc incorporation of the ﬁber cassette into replicative adenovirus. Only following recombination into a viral genome can the modiﬁed ﬁber
gene be expressed. The resulting recombinant virus will be packaged in the newly synthesized modiﬁed-ﬁber capsids and ampliﬁed in other cell lines,
such as 911–S11.
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half-mutant lox sites. As delineated by Langer et al. (15),
the use of these specialized lox sites results in a
unidirectional gene exchange with maintained orientation
and lack of alternative recombination events. In the
presence of Cre Recombinase, the ﬁber gene cassette
replaces SacB, placing ﬁber in the natural location of the
adenovirus genome. By including the natural TPL splice-
acceptor sequence in the ﬁber shuttles, upstream lox sites
are not included in the ﬁnal spliced ﬁber transcript.
Fibergene exchange in E. coli and mammalian cells
The vector system is ﬂexible, allowing one to shuttle ﬁber
cassettes into adenoviral plasmids in E. coli or replicating
adenovirus genomes in mammalian cells (Figure 1A and
B, respectively). When generating recombinant adenoviral
plasmids, the modiﬁed-ﬁber cassette can be recombined
from the smaller ﬁber shuttle vectors (RP-FBR or RPuc-
FBR) into the larger viral genomic plasmid vector (pFex)
either before or after incorporation of a modiﬁed E1 gene
cassette. For example, if a single E1 cassette is to be tested
with multiple ﬁber modiﬁcations, one can ﬁrst generate
E1-pFex (Figure 1A, top), followed by recombination
with diﬀerent ﬁber shuttles. Alternatively, if a single ﬁber
modiﬁcation is to be studied in the background of multiple
E1 cassettes, one can generate a pFex-ﬁber (Figure 1A,
bottom), followed by recombination with diﬀerent E1
cassettes. The pFex vector is compatible with all AdEasy-
based E1 shuttle vectors.
The E1 region shuttles are recombined into pFex
through traditional RecA-mediated homologous recombi-
nation in E. coli, such as BJ5183 (Figure 2A). Eﬃciency of
this step can be enhanced by generating stable pFex
containing BJ5183 coli, as has been shown with the
AdEasier method (14). Fiber cassette insertion, on the
other hand, is completed in 294cre E. coli by temperature-
induced expression of Cre recombinase (17). The desired
modiﬁed-ﬁber clones can be selected through appropriate
antibiotic resistance and growth on plates containing 5%
sucrose, which negatively selects against SacB-containing
Figure 2. E1 and ﬁber cassette exchange in plasmid vectors. (A) PacI
restriction digestion of parental vector, pFex, and resulting recombi-
nant vectors pAdTrack-Fex and pAdTrack-Luc-Fex following E1
cassette exchange in BJ5183 E. coli. The corresponding E1 Cassettes
contain an additional PacI site, which results in the diagnostic 4.6Kb
band (arrow). (B) PCR across a single lox site of 294cre clones
demonstrates the presence of ﬁber containing pFex (50-primer within
ﬁber gene and 30-primer within pFex). The shuttle control does not
contain lox sites and therefore does not recombine with pFex. On the
other hand, PCR within the pFex vector demonstrates presence of the
‘acceptor’ pFex in both RP-Fib and shuttle-control samples. (C) XhoI
restriction digest of 12 mini-preps randomly screened for the presence
of the desired ﬁber-containing clone following ﬁber cassette exchange
into pFex. The ﬁber gene contains an additional XhoI site, which
generates the diagnostic 3.6Kb product (arrow). All of the screened
clones contained the desired plasmid product.
Figure 3. Evaluation of adenovirus generated by the pFex system.
(A) Viral burst comparison of pFex derived and AdEasy derived virus,
both containing wild-type ﬁber, demonstrates equal replication and
spreading rate as indicated by GFP-positive viral burst size. (B) Equal
PFU of puriﬁed adenovirus containing wild-type ﬁber (AdTrack-
WTFib), CAR-ablated ﬁber (TAYT) or CAR ablated and RGD4C
retargeted ﬁber (TAYT-RGD) were boiled and evaluated by western
blotting (top gel). Similar ﬁber quantities and appropriate size are
demonstrated. Viral DNA of equal PFU of puriﬁed adenovirus was
also subjected to PCR to evaluate content, size and homogeneity of the
ﬁber-HI loop region (lower two gels). The larger ﬁber-PCR band of
AdTrack-RGD4C-2 (TAYT-RGD) is caused by the peptide encoding
region. AdTrack-FBR2 (TAYT) and AdTrack-WTFib (wild-type) do
not contain recombinant HI loop peptides and therefore have identical
size HI loop products. Hexon PCR was included as a reference control.
(C) PC-3 and PC3-CAR prostate cancer cells were infected with 100
MOI of wild-type, CAR-ablated (TAYT) and CAR-ablated and
integrin retargeted (TAYT-RGD) GFP-expressing adenovirus.
Infected cells were identiﬁed by GFP-positive ﬂuorescent microscopy.
As predicted, TAYT mutation completely detargeted virus and
inclusion of the integrin targeting peptide, RGD4C, restored viral
infection in a CAR independent manner.
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conﬁrmed in 294cre E. coli by colony PCR (Figure 2B).
Plasmid-based eﬃciency of ﬁber gene exchange with this
system is considerably better than previously reported
RecA-mediated ﬁber gene recombinations (18). With
pFex, often 100% of screened clones contain the ﬁber of
interest (Figure 2C). Further, the eﬃciency is such that
a few thousand clones can be generated in a small volume
reaction (Supplementary Table 1).
In addition to plasmid-gene exchange, the pFex system
allows modiﬁed-ﬁber cassettes to be transferred directly
and site speciﬁcally into mature pFex-based viral gen-
omes. To achieve this, pFex vectors are pseudotyped
(packaged in cells that express wild-type ﬁber) and used
to infect a Cre recombinase expressing mammalian cell
that has been transfected with a ﬁber shuttle plasmid
(Figure 1B). The modiﬁed-ﬁber gene is only expressed
following recombination into the genome of a replicating
pFex virus. Thus, only the desired recombinant virus will
propagate (see Figure 3, viral burst). In the following
sections, we use this methodology to generate numerous
infective adenoviruses (Tables 1 and 2), including a library
of adenoviruses displaying various peptides in the ﬁber
HI-loop.
pFex derived adenovirus
The modiﬁcations of the pFex vector do not impart any
negative eﬀects on viral propagation. To conﬁrm this,
we used pFex vectors to generate a virus containing
wild-type adenovirus serotype 5 (Ad5) ﬁber using the
cellular recombination method outlined in Figure 1B.
The resulting virus, AdTrack-WTFib, is identical to the
traditionally generated AdTrack-AdEasy virus, except for
the incorporated lox sites. We then simultaneously
ampliﬁed, puriﬁed and titered both viruses to observe
any diﬀerences. Both viruses produced identical infectious
titers (PFU) (Table 1). We further compared viral
packaging and spread through viral burst assays.
Speciﬁcally, 293 cells were infected with each virus at
MOI less than 1 and evaluated for viral replication and
spread by burst size. Viral bursts were visualized at early
stages by GFP ﬂuorescent microscopy and ﬁve randomly
selected bursts from each sample were measured (longest
point diameter). AdTrack-AdEasy and AdTrack-WTFib
had identical burst size, indicating little to no diﬀerence
between AdEasy versus pFex derived virus (Figure 3A).
We conclude that the incorporated lox sites in pFex have
no signiﬁcant inhibitory impact on viral lifecycle or
production.
We then applied the pFex system to generate previously
characterized tropism-modiﬁed adenovirus for proof
of principal. First, the natural CAR-mediated infection
pathway was ablated through FG loop mutation
(T489AYT492) (19). These CAR detargeted viruses
(referred to as TAYT) were then redirected to bind
and infect cells via integrins by inserting the cysteine-
constrained, integrin-binding peptide RGD4C
(CDCRGDCFC) into the ﬁber HI-loop (20). Puriﬁed
particles of these two viruses, AdTrack-FBR2 (TAYT)
and AdTrack-RGD4C-2 (TAYT-RGD) contain only
the desired recombinant ﬁber DNA and recombinant ﬁber
protein at expected size and proportions (Figure 3B).
Table 1. AdEasy and pFex derived vectors
Name Parent vector E1 cassette Fiber cassette PFU/ml VP/ml
AdTrack-AdEasy
a pAdEasy-1 CMV-GFP – 2.2 10
9 4 10
11
AdTrack-WTFib
a pFex CMV-GFP Wild Type Fiber 1.7 10
9 1.9 10
12
AdTrack-FBR2
b pFex CMV-GFP TAYT 1.8 10 2.4 10
11
AdTrack-RGD4C-2
b pFex CMV-GFP TAYT +RGD4C 3.0 10
7 4.9 10
11
aVirus ampliﬁed, puriﬁed and titered simultaneously (equal time and volumes at all steps).
bTiter determined on 911-S11 cells.
Table 2. Peptide library and selected recombinant viruses
Name E1 cassette CAR
binding
Fiber
cassette
PFU/ml
AdTrack-FBR2-6X CMV-GFP TAYT XXXXXX –
AdTrack-FBR2-A2 CMV-GFP TAYT TGEKGG 1.6 10
5
AdTrack-FBR2-A3 CMV-GFP TAYT GGAAGA 1.4 10
6
AdTrack-FBR2-A4 CMV-GFP TAYT GGGDRG 1.6 10
6
Titer determined on 911-S11 cells, X–refers to randomized peptide
sequence.
Figure 4. Eﬃciency and sensitivity of ﬁber gene exchange. Serial
dilution mixing experiments demonstrate ﬁber cassette exchange
sensitivity. Fiber shuttle RPuc-WTFib was serially diluted from 1:10
to 1:1000000 and mixed into a constant amount of mutant Rpuc-
Fib1R1 (N541S) plasmid. This plasmid mix was recombined into
AdTrack-pFex genomes by transfection into 293cre57 cells infected
with pseudotyped AdTrack-Fex at an MOI of 1. Cell lysates were used
to infect 293 cells, which were then overlayed by agar. Recombinant
AdTrack-WTFib viruses were identiﬁed by viral burst (block arrow).
At least a single viral burst was detectable in dilutions of 1:10000 to
1:100000 wild-type ﬁber shuttle, indicating a sensitivity of 0.01–
0.001%. Some non-spreading viral infections were present (small
arrows), indicating infection by AdTrack-pFex or AdTrack-N541S,
which was pseudotyped in cells co-inhabited by AdTrack-WTFib viral
genomes. Fiber N541S alone control (0:1) was unable to create any
viral bursts.
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eceptor (11), were used to propagate and titer these CAR-
ablated vectors. In cell infection assays, ﬁber FG loop
mutation predictably ablates CAR mediated infection of
PC-3 and PC3-CAR prostate cancer cell lines (Figure 3C).
The incorporation of the integrin targeting peptide
expectedly provides an alternative infection pathway for
both cell lines. Notably, the CAR overexpressing cell line,
PC3-CAR, was infected by wild-type ﬁber adenovirus
(AdTrack-WTFib) at a higher rate than the parental PC-3
cell line, which is known to express lower levels of CAR
(12). On the other hand, the CAR detargeted and integrin
retargeted virus (TAYT-RGD) infected both PC-3 and
PC3-CAR cell lines with equal eﬃciency. Though integrin
retargeted infection is low when compared to wild-type
ﬁber in this cell line ( 5%), such vectors are valuable
for infecting cancer cells, which often lack CAR expres-
sion (2). These results conﬁrm previous reports of FG
loop detargeting and the subsequent retargeted infection
through capsid-displayed integrin-binding peptides
(21,22).
Efficiency and sensitivity ofgenerating modified
adenovirus with pFex
Cre–lox recombination oﬀers a means to site speciﬁcally
recombine gene cassettes into large vectors, including
cellular genomes. However, in traditional Cre–lox recom-
bination, the symmetric lox site remains unchanged
following recombination. Thus, the reactant and product
are identical and the reverse reaction occurs with equal
eﬃciency. Langer et al. (15) have overcome this limitation
by designing half-mutant lox sites, which, after recombi-
nation, produce a unique and non-functional product in
the donor vector, rendering the reaction unidirectional.
The application of this unidirectional cassette exchange
theoretically provides added eﬃcacy by preventing any
reverse recombination over time.
In vitro evaluation of gene exchange eﬃciency was
evaluated with four separate ﬁber shuttle vectors. In this
plasmid-based gene exchange, numerous ﬁber gene
cassettes were recombined into the 34Kb pFex plasmid,
producing  1800 recombinant clones per milliliter of
transformation culture in the absence of detectable back-
ground (Supplementary Table S1). While this eﬃciency
could be easily scaled to generate a large diversity plasmid
library, direct translation to active adenoviral particles is
unrealistic. Therefore, the true value of the system is best
evaluated by the ability to generate recombinant infectious
virus.
To evaluate the eﬃciency of exchanging modiﬁed ﬁber
genes into viral genomes in mammalian cells (Figure 1B),
we performed serial dilution mixing experiments using a
wild-type ﬁber shuttle (Rpuc-WTFib) and a non-infective
ﬁber mutant (N541S) shuttle. Recombinant AdTrack-
WTFib virus produces GFP-positive viral bursts visible
by ﬂuorescent microscopy in agar overlayed 293 cells
(Figure 4, large arrow), where AdTrack-N541S is non-
infective. The wild-type ﬁber shuttle was serially diluted
(1:10 to 1:1000000) and mixed into a constant amount
of mutant ﬁber shuttle, and the resulting plasmid mixes
were transfected into 293cre57 cells, which were simulta-
neously infected with pseudotyped AdTrack-Fex virus
(MOI=1). Five days after transfection and infection,
recombinant viral pools were harvested and applied
to 293 cells with agar overlay, in order to determine
the sensitivity of detecting spreading AdTrack-WTFib
virus (as indicated by a GFP-positive viral burst). This is
the most stringent assay possible as adenovirus with ﬁber
N541S mutation do not produce infective virus particles.
Therefore, this mutant ﬁber protein will potentially
hybridize and compete with the wild-type ﬁber in a
co-infected or co-transfected cell. A sensitivity of
0.01–0.001% was determined by ﬁnding at least one
viral burst in ratios of 1 WTFib shuttle to 10000 or
100000 ﬁber-N541S mutant shuttles (Figure 4). This
success is unprecedented for ﬁber gene exchange and
suggests that ﬁber peptide adenovirus libraries can be
simultaneously generated and screened for the ability to
create infective and spreading virus.
Adenoviral peptide library screen for retargeted infection
For proof of principal, we generated and screened a low
diversity ﬁber-displayed hexapeptide adenovirus library
(Table 2). A random peptide cassette was cloned into the
HI-loop of the CAR-ablated (TAYT) ﬁber shuttle,
RPuc-FBR2. The resulting plasmid library (RPuc-FBR2-
6X) produced  16000 plasmid clones, reﬂecting the
maximum diversity. One million 293cre57 cells were
transfected with 3mg of RPuc-FBR2-6X and infected
with pseudotyped pAdTrack-Fex (MOI of 1). Five
days later, the recombinant virus pool was harvested.
The 293 cells were then infected to identify CAR-
independent viral plaques. Both positive (RPuc-WTFib)
and negative (N541S) control samples were included in
this experiment for reference purposes.
Viral burst from each sample were quantiﬁed 48h post-
infection. In comparison to the wild-type control, the
FBR2-6X library produced  0.075% of the number of
bursts. There were no infected cells bursts in the negative
(N541S) control. Individual plaques were randomly
isolated and ampliﬁed in 24-well plates. Aliquots were
taken for PCR ampliﬁcation of the ﬂoxed ﬁber cassette.
The resulting PCR product was then recombined with
RPuc-Rescue, an acceptor plasmid that contains half-
mutant lox sites ﬂanking a SacB gene for sucrose selection,
in 294cre E. coli (Figure 5). Once recombined into RPuc-
Rescue, the cloned ﬁber gene is available for sequencing,
further modiﬁcation, or recombination with pFex viral
genomes to create a subsequent virus.
Three plaques from the hexapeptide library were cloned
and sequenced to identify three unique peptides (Table 2).
These clones were ampliﬁed, puriﬁed, titered and evalu-
ated for retargeting ability in comparison to CAR-ablated
virus. Adenovirus AdTrack-FBR2-A2 (TAYT-A2) was
poorly propagated in 293 cells, possibly due to peptide
inhibition during packaging. The two remaining viruses,
FBR2-A3 and FBR-2A4, do propagate and are capable
of retargeting adenoviral infection to 293 cells
(Supplementary Figure S1). To evaluate if this infection
was CAR-independent, we knocked down CAR protein
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CAR siRNAs. CAR-speciﬁc knock-down by both
siRNAs reduced wild-type ﬁber infection by over 50%,
but did not reduce the number of infected A3, A4 or RGD
peptide retargeted viruses (Figure 6A). This infection rate
was also quantiﬁed by ﬂuorometer (Supplementary
Figure 2A). Further, we evaluated the infection rates of
these viruses in PC-3 and the CAR overexpressing subline,
PC3-CAR. Wild-type adenovirus infected PC3-CAR cells
with 26-fold better eﬃciency than the low CAR expressing
PC-3 parental cell line. However, CAR overexpression did
not enhance the infection rate of the A3, A4 or RGD
peptide retargeted virus (Figure 6B and Supplementary
Figure 2B). Notably, the infection rate of the A3
retargeted virus was superior to the RGD retargeted
virus in both cell lines. These experiments indicate that the
ligand for FBR2-A3 and FBR2-A4 viruses is expressed
in both 293 cells and PC-3 prostate cancer cells.
DISCUSSION
The ﬁber capsid protein is responsible for the initial
interaction between the virus and the cell, through
high-aﬃnity binding with the cellular receptor, CAR
(23,24), followed by internalization, which is triggered by
viral penton base interaction with cellular integrins (25).
The ﬁber gene is the ﬁfth and last gene in the MLTU, an
approximately  29Kb, multiple open reading frame
(ORF) transcript expressed late in the viral lifecycle
(26). Alternative splicing of the MLTU links each
ORF with a 50-leader for preferential translation and a
30-polyadenylation site (27–29). When designing ﬁber
gene-modiﬁed virus, one must avoid interrupting splice
donor and acceptor sites because they cannot only aﬀect
ﬁber, but also other ORF in the MLTU. Apart from
splicing, modiﬁcation of the ﬁber coding region can also
negatively aﬀect ﬁber protein folding, trimerization,
assembly into the virus and therefore viral production.
The HI-loop, a serotype variable region, is an accepted site
for incorporating targeting motifs while still allowing
successful viral propagation (30). However, each ligand is
unique and may aﬀect ﬁber diﬀerently (31). Additionally,
incorporation of a targeting peptide into the ﬁber protein
backbone may interfere with the ability of the peptide to
bind its ligand. Therefore, rigorous evaluation of each
retargeted virus is required to conﬁrm that they have no
deleterious eﬀects on viral production or peptide–ligand
binding. Because of these potential problems, and the time
and eﬀort required to make genetically retargeted virus,
there is signiﬁcant risk in pursuing these projects.
For this reason, adenoviral display peptide libraries
have been a signiﬁcant, yet diﬃcult goal in adenoviral
biotechnology. While high diversity libraries can be
generated in plasmid form, transformation to a packaged
adenovirus library is diﬃcult due to ineﬃciencies in
transfecting the large viral genome and low rates of
conversion to a packaged and infective adenovirus.
Figure 5. Schematic for generating, selecting and rescuing adenoviral
peptide libraries. Clockwise from top left: CAR-ablated ﬁber-peptide
library cassettes are unidirectionally shuttled into ﬁber-less pFex viral
genomes in 293cre57 cells. Some of the resulting CAR detargeted and
peptide retargeted viruses infect the target cells. Resulting viral plaques
can be isolated and ampliﬁed. The ﬂoxed ﬁber cassette can be ampliﬁed
by PCR and recombined with RPuc-Rescue in 294cre E. coli. Growth
in appropriate antibiotics and 5% sucrose selects new ﬁber shuttles
that are directly applicable to sequencing, further modiﬁcation or
recombination to generate new virus in plasmid or viral form.
Figure 6. CAR-independent infection by selected retargeted adenovirus.
(A) The 293 cells were transfected with two separate anti-CAR siRNAs,
a negative control siRNA or non-transfected (UNT). Cells were
infected with each virus at an MOI of 1, 72h after transfection.
Infected GFP-positive cells were visible the following day by ﬂuorescent
microscopy (6 ) at equal exposure times. The infection rate of
adenoviruses with wild-type ﬁber was reduced by over 50% with
both anti-CAR siRNAs. CAR knock-down had no eﬀect on infected
cell numbers in CAR-detargeted and peptide retargeted viruses (B) PC-
3 and the CAR overexpressing subline, PC3-CAR, were infected with
each virus at an MOI of 10. Infected GFP-positive cells were visible the
following day by ﬂuorescent microscopy (6 ) at equal exposure times.
The infection rate of adenoviruses with wild-type ﬁber increased several
fold in the CAR overexpressing line. However, there was no visible
increase in infected cell number in CAR-detargeted and peptide
retargeted viruses.
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of 2–5mg of linearized adenoviral plasmid DNA
( 5 10
10 1 10
11 plasmid particles) into 2 10
6 293
cells to obtain full infection within 7–10 days. This
corresponds to an MOI of 50000. On the other hand,
infection with an MOI of 1 will generally provide full
infection in less than half the time. Therefore, the
eﬃciency of viral production is several logs better with
infection when compared to transfection. While it is
notable that conjugation of terminal protein complex can
improve the conversion rate of viral DNA into packaged
adenoviral particles by a few logs (32), this eﬃciency is still
far below that of natural viral infection. Here, we describe
a methodology to produce ﬁber peptide libraries by
applying the large ‘acceptor’ vector as a packaged and
infective virus that genetically lacks the ﬁber gene.
The ﬁber peptide library is then transferred from a
small, more easily transfected shuttle, into infected
adenoviral genomes in mammalian cells. The ﬁber protein
is only expressed following successful gene transfer, thus
only recombinant virus will properly package and
propagate. This step overcomes the major limitation of
converting the large linearized viral plasmid genome into a
packageable and infectious adenovirus particle.
Through serial dilution mixing experiments, we demon-
strate that, with this system, libraries of at least 10
5 can be
generated and screened to identify successfully propagat-
ing virus (Figure 4). These pilot studies, completed in
6-well dishes, can be easily expanded to increase the
applicable diversity. Moreover, the applicable diversity
may be improved by transfecting smaller amounts of the
shuttle plasmid library (to achieve a low plasmid copy
number per cell) during library generation. This could
potentially minimize the number of chimeric viruses
formed during this ﬁrst step. Later, during library
selection and ampliﬁcation, there is the possibility of
co-infection by a neighboring virus. The resulting
co-infection would create chimeric viruses, potentially
inhibiting the propagation of a successful clone. With the
pFex Rescue system (Figure 5), successful clones can be
rescued from infected cells by PCR and recombined back
into the RPuc-Rescue plasmid. This step, while applied to
individual plaques in our screen, can also be applied to a
population of cells infected with a viral pool. With this
methodology, one can avoid the negative eﬀects associated
with amplifying a viral pool. The resulting rescue plasmids
produce working ﬁber shuttles, which can be sequenced,
applied to generate a new viral clone or applied as a pool
to a second round of library selection (Figure 5).
Here, a single round of selection was applied to a
moderately diverse library of 16000 potential ﬁber-
displayed hexapeptides to identify adenoviruses which
infect cells in a CAR independent manner. With a
projected three amino acid diversity of 8000
(20
3=8000), this library should contain at least one
integrin targeting RGD motif, currently one of the best
peptide motifs for retargeting adenoviruses to CAR-
deﬁcient cells. One of the selected peptides, A3, redirects
infection of detargeted viruses to 293, PC-3 and PC3-CAR
cells at higher levels than the widely applied integrin
targeting peptide, RGD4C. The selected retargeting
peptides, like RGD and other peptides, appear to reduce
the overall output of infectious viruses (PFU). However, it
is possible that additional rounds of biopanning may
select for peptides which not only infect the target cell, but
also minimize interference with ﬁber protein folding and
capsid assembly (i.e. more favorable viral particle to PFU
ratios). We anticipate that the pFex system can be used in
this way to generate and screen higher diversity libraries
through iterative selection rounds, as outlined in Figure 5,
to identify CAR-independent adenovirus to most any cell
type.
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